| Year |
Citation |
Score |
| 2022 |
Bouchelaghem R, Mader S, Gaboury L, Messarah M, Boumendjel M, Boumendjel A. Estrogens desensitize MCF-7 breast cancer cells to apelin-induced autophagy and enhanced growth under estrogen starvation: a possible implication in endocrine resistance. Cellular and Molecular Biology (Noisy-Le-Grand, France). 68: 113-124. PMID 36905266 DOI: 10.14715/cmb/2022.68.9.18 |
0.3 |
|
| 2022 |
Vallet A, El Ezzy M, Diennet M, Haidar S, Bouvier M, Mader S. The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens. The Journal of Biological Chemistry. 102757. PMID 36460099 DOI: 10.1016/j.jbc.2022.102757 |
0.434 |
|
| 2022 |
Hosfield DJ, Weber S, Li NS, Suavage M, Joiner CF, Hancock GR, Sullivan EA, Ndukwe E, Han R, Cush S, Lainé M, Mader SC, Greene GL, Fanning SW. Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in mutant breast cancer cells. Elife. 11. PMID 35575456 DOI: 10.7554/eLife.72512 |
0.443 |
|
| 2021 |
Dodat F, Mader S, Lévesque D. Minireview: what is known about SUMOylation among NR4A family members? Journal of Molecular Biology. 167212. PMID 34437889 DOI: 10.1016/j.jmb.2021.167212 |
0.329 |
|
| 2020 |
Dodat F, Cotnoir-White D, Dianati E, Vallet A, Mader S, Lévesque D. Complex regulation of orphan nuclear receptor Nur77 (Nr4a1) transcriptional activity by SUMO2 and PIASγ. Biochimica Et Biophysica Acta. Molecular Cell Research. 118908. PMID 33189785 DOI: 10.1016/j.bbamcr.2020.118908 |
0.365 |
|
| 2020 |
Ghanbari F, Mader S, Philip A. Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells. Cells. 9. PMID 32717915 DOI: 10.3390/Cells9081765 |
0.394 |
|
| 2020 |
Ghanbari F, Mader S, Philip A. Abstract 4375: Inhibition of triple negative breast cancer cell progression using estrogen related receptor alpha endogenous ligands Epidemiology. DOI: 10.1158/1538-7445.Am2020-4375 |
0.442 |
|
| 2019 |
Ghanbari F, Hebert-Losier A, Barry J, Poirier D, Giguere V, Mader S, Philip A. Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine. The Journal of Steroid Biochemistry and Molecular Biology. PMID 30954508 DOI: 10.1016/J.Jsbmb.2019.04.001 |
0.417 |
|
| 2019 |
Kulpa J, Wang X, Dianati E, Diennet M, Audemard E, Mader S. SUN-011 Identification Of Regulators Of Estrogenic Signalling In ER-positive Breast Cancer Cells By Whole Genome shRNA Screening Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-011 |
0.347 |
|
| 2019 |
Ghanbari F, Mader S, Philip A. Abstract 1003: Modulating estrogen related receptors (ERRs) activity in breast cancer using endogenous ligands Cancer Research. 79: 1003-1003. DOI: 10.1158/1538-7445.Sabcs18-1003 |
0.488 |
|
| 2018 |
Traboulsi T, El Ezzy M, Dumeaux V, Audemard E, Mader S. Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells. Oncogene. PMID 30190545 DOI: 10.1038/s41388-018-0468-9 |
0.449 |
|
| 2018 |
Mathieu M, Paradis A, Pelletier S, Hébert S, Boutin K, Audemard É, Mader S, Kleinman C, Turcotte S. Abstract 4670: Evidence of neoantigen-reactive T cell response in a case of relapsing, mismatch-repair gene proficient, colorectal cancer Cancer Research. 78: 4670-4670. DOI: 10.1158/1538-7445.Am2018-4670 |
0.305 |
|
| 2016 |
Traboulsi T, El Ezzy M, Gleason J, Mader S. Antiestrogens: structure activity relationships and use in breast cancer treatment. Journal of Molecular Endocrinology. PMID 27729460 DOI: 10.1530/Jme-16-0024 |
0.364 |
|
| 2016 |
Mathieu M, Pelletier S, Laperrière D, Mader S, Turcotte S. Abstract A084: Identification of mutation-reactive T cells in patients with gastrointestinal cancers Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A084 |
0.327 |
|
| 2015 |
Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, Aleynikova O, Basik M. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Research. 75: 4351-63. PMID 26297734 DOI: 10.1158/0008-5472.Can-14-3475 |
0.303 |
|
| 2015 |
Giner XC, Cotnoir-White D, Mader S, Lévesque D. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 4256-67. PMID 26148973 DOI: 10.1096/fj.14-259804 |
0.309 |
|
| 2015 |
Cotnoir-White D, Miller A, Zhao B, Weiss I, Gleason J, Bettoun D, Mader S. Abstract 5341: Bifunctional integrated molecules with combined retinoic acid receptor agonist/protein deacetylase inhibitory activities as therapeutic agents for breast cancer and neuroblastoma Cancer Research. 75: 5341-5341. DOI: 10.1158/1538-7445.Am2015-5341 |
0.383 |
|
| 2012 |
Hilmi K, Hussein N, Mendoza-Sanchez R, El-Ezzy M, Ismail H, Durette C, Bail M, Rozendaal MJ, Bouvier M, Thibault P, Gleason JL, Mader S. Role of SUMOylation in full antiestrogenicity. Molecular and Cellular Biology. 32: 3823-37. PMID 22826433 DOI: 10.1128/Mcb.00290-12 |
0.648 |
|
| 2011 |
Cotnoir-White D, Laperrière D, Mader S. Evolution of the repertoire of nuclear receptor binding sites in genomes. Molecular and Cellular Endocrinology. 334: 76-82. PMID 21056084 DOI: 10.1016/j.mce.2010.10.021 |
0.322 |
|
| 2010 |
Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, Dionne S, Servant MJ, Bitton A, Seidman EG, Mader S, Behr MA, White JH. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. The Journal of Biological Chemistry. 285: 2227-31. PMID 19948723 DOI: 10.1074/Jbc.C109.071225 |
0.352 |
|
| 2009 |
Palijan A, Fernandes I, Verway M, Kourelis M, Bastien Y, Tavera-Mendoza LE, Sacheli A, Bourdeau V, Mader S, White JH. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression. The Journal of Biological Chemistry. 284: 30275-87. PMID 19744932 DOI: 10.1074/Jbc.M109.051201 |
0.465 |
|
| 2009 |
Palijan A, Fernandes I, Bastien Y, Tang L, Verway M, Kourelis M, Tavera-Mendoza LE, Li Z, Bourdeau V, Mader S, Yang XJ, White JH. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. The Journal of Biological Chemistry. 284: 30264-74. PMID 19744931 DOI: 10.1074/Jbc.M109.045526 |
0.48 |
|
| 2009 |
Gionet N, Jansson D, Mader S, Pratt MA. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Journal of Cellular Biochemistry. 107: 448-59. PMID 19350539 DOI: 10.1002/Jcb.22141 |
0.446 |
|
| 2008 |
Mader S. Fast-tracking steroid receptor crystallization. Nature Chemical Biology. 4: 226-7. PMID 18347588 DOI: 10.1038/Nchembio0408-226 |
0.409 |
|
| 2008 |
Bourdeau V, Deschênes J, Laperrière D, Aid M, White JH, Mader S. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Research. 36: 76-93. PMID 17986456 DOI: 10.1093/Nar/Gkm945 |
0.464 |
|
| 2007 |
Brodeur H, Parisotto M, Chagnon S, Mader S, Bhat PV. Isomer-specific retinoic acid biosynthesis in HeLa cells expressing recombinant class I aldehyde dehydrogenases. Biochimica Et Biophysica Acta. 1770: 1548-56. PMID 17916406 DOI: 10.1016/J.Bbagen.2007.07.013 |
0.313 |
|
| 2007 |
Quignodon L, Grijota-Martinez C, Compe E, Guyot R, Allioli N, Laperrière D, Walker R, Meltzer P, Mader S, Samarut J, Flamant F. A combined approach identifies a limited number of new thyroid hormone target genes in post-natal mouse cerebellum. Journal of Molecular Endocrinology. 39: 17-28. PMID 17601882 DOI: 10.1677/Jme-06-0054 |
0.313 |
|
| 2007 |
Nguyen D, Bail M, Pesant G, Dupont VN, Rouault E, Deschênes J, Rocha W, Melançon G, Steinberg SV, Mader S. Rational design of an estrogen receptor mutant with altered DNA-binding specificity. Nucleic Acids Research. 35: 3465-77. PMID 17478511 DOI: 10.1093/Nar/Gkm241 |
0.646 |
|
| 2007 |
Deschênes J, Bourdeau V, White JH, Mader S. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. The Journal of Biological Chemistry. 282: 17335-9. PMID 17463000 DOI: 10.1074/Jbc.C700030200 |
0.495 |
|
| 2007 |
Lupien M, Jeyakumar M, Hébert E, Hilmi K, Cotnoir-White D, Loch C, Auger A, Dayan G, Pinard GA, Wurtz JM, Moras D, Katzenellenbogen J, Mader S. Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12. Molecular Endocrinology (Baltimore, Md.). 21: 797-816. PMID 17299137 DOI: 10.1210/Me.2006-0074 |
0.772 |
|
| 2007 |
Laperriere D, Wang TT, White JH, Mader S. Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution. Bmc Genomics. 8: 23. PMID 17239240 DOI: 10.1186/1471-2164-8-23 |
0.454 |
|
| 2006 |
Tavera-Mendoza LE, Mader S, White JH. Genome-wide approaches for identification of nuclear receptor target genes. Nuclear Receptor Signaling. 4: e018. PMID 16862224 DOI: 10.1621/Nrs.04018 |
0.411 |
|
| 2006 |
Dayan G, Lupien M, Auger A, Anghel SI, Rocha W, Croisetière S, Katzenellenbogen JA, Mader S. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha. Molecular Pharmacology. 70: 579-88. PMID 16679488 DOI: 10.1124/Mol.105.021931 |
0.651 |
|
| 2006 |
Tavera-Mendoza L, Wang TT, Lallemant B, Zhang R, Nagai Y, Bourdeau V, Ramirez-Calderon M, Desbarats J, Mader S, White JH. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. Embo Reports. 7: 180-5. PMID 16322758 DOI: 10.1038/Sj.Embor.7400594 |
0.386 |
|
| 2006 |
Mann KK, Davison K, Colombo M, Colosimo AL, Diaz Z, Padovani AM, Guo Q, Scrivens PJ, Gao W, Mader S, Miller WH. Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicology Letters. 160: 158-70. PMID 16112521 DOI: 10.1016/J.Toxlet.2005.06.017 |
0.508 |
|
| 2005 |
Rocha W, Sanchez R, Deschênes J, Auger A, Hébert E, White JH, Mader S. Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells. Molecular Pharmacology. 68: 1852-62. PMID 16186250 DOI: 10.1124/Mol.105.014514 |
0.464 |
|
| 2005 |
Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Molecular Endocrinology (Baltimore, Md.). 19: 2685-95. PMID 16002434 DOI: 10.1210/Me.2005-0106 |
0.366 |
|
| 2004 |
Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH, Hanrahan JH. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology (Baltimore, Md. : 1950). 173: 2909-12. PMID 15322146 DOI: 10.4049/Jimmunol.173.5.2909 |
0.302 |
|
| 2004 |
White JH, Fernandes I, Mader S, Yang XJ. Corepressor recruitment by agonist-bound nuclear receptors. Vitamins and Hormones. 68: 123-43. PMID 15193453 DOI: 10.1016/S0083-6729(04)68004-6 |
0.511 |
|
| 2004 |
Bourdeau V, Deschênes J, Métivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Molecular Endocrinology (Baltimore, Md.). 18: 1411-27. PMID 15001666 DOI: 10.1210/Me.2003-0441 |
0.456 |
|
| 2003 |
Mercier I, Mader S, Calderone A. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. Cardiovascular Research. 59: 883-92. PMID 14553828 DOI: 10.1016/S0008-6363(03)00517-0 |
0.43 |
|
| 2003 |
Rousseau C, Pettersson F, Couture MC, Paquin A, Galipeau J, Mader S, Miller WH. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 86: 1-14. PMID 12943740 DOI: 10.1016/S0960-0760(03)00255-3 |
0.571 |
|
| 2003 |
Davison K, Côté S, Mader S, Miller WH. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia. 17: 931-40. PMID 12750708 DOI: 10.1038/Sj.Leu.2402876 |
0.318 |
|
| 2003 |
Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee HS, Eng F, Bertos NR, Pelletier N, Mader S, Han VK, Yang XJ, White JH. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Molecular Cell. 11: 139-50. PMID 12535528 DOI: 10.1016/S1097-2765(03)00014-5 |
0.493 |
|
| 2002 |
Guimond J, Devost D, Brodeur H, Mader S, Bhat PV. Characterization of the rat RALDH1 promoter. A functional CCAAT and octamer motif are critical for basal promoter activity. Biochimica Et Biophysica Acta. 1579: 81-91. PMID 12427543 DOI: 10.1016/S0167-4781(02)00510-9 |
0.419 |
|
| 2002 |
Barsalou A, Dayan G, Anghel SI, Alaoui-Jamali M, Van de Velde P, Mader S. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells. Molecular and Cellular Endocrinology. 190: 65-73. PMID 11997179 DOI: 10.1016/S0303-7207(02)00011-4 |
0.473 |
|
| 2002 |
Sanchez R, Nguyen D, Rocha W, White JH, Mader S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 24: 244-54. PMID 11891761 DOI: 10.1002/Bies.10066 |
0.466 |
|
| 2001 |
Nguyen D, Steinberg SV, Rouault E, Chagnon S, Gottlieb B, Pinsky L, Trifiro M, Mader S. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome Molecular Endocrinology. 15: 1790-1802. PMID 11579211 DOI: 10.1210/Mend.15.10.0709 |
0.41 |
|
| 2001 |
Akutsu N, Bastien Y, Lin R, Mader S, White JH. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma Biochemical and Biophysical Research Communications. 281: 1051-1056. PMID 11237771 DOI: 10.1006/Bbrc.2001.4466 |
0.357 |
|
| 2000 |
Jaalouk DE, Eliopoulos N, Couture C, Mader S, Galipeau J. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells Human Gene Therapy. 11: 1837-1849. PMID 10986557 DOI: 10.1089/10430340050129468 |
0.308 |
|
| 2000 |
Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene. 19: 3460-3469. PMID 10918604 DOI: 10.1038/Sj.Onc.1203685 |
0.391 |
|
| 2000 |
Anghel SI, Perly V, Melançon G, Barsalou A, Chagnon S, Rosenauer A, Miller WH, Mader S. Aspartate 351 of estrogen receptor alpha is not crucial for the antagonist activity of antiestrogens. The Journal of Biological Chemistry. 275: 20867-72. PMID 10787412 DOI: 10.1074/Jbc.M002098200 |
0.368 |
|
| 1998 |
Eng FC, Barsalou A, Akutsu N, Mercier I, Zechel C, Mader S, White JH. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain. The Journal of Biological Chemistry. 273: 28371-7. PMID 9774463 DOI: 10.1074/Jbc.273.43.28371 |
0.502 |
|
| 1998 |
Le Bihan S, Marsaud V, Mercier-Bodard C, Baulieu EE, Mader S, White JH, Renoir JM. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Molecular Endocrinology (Baltimore, Md.). 12: 986-1001. PMID 9658403 DOI: 10.1210/Mend.12.7.0128 |
0.523 |
|
| 1998 |
Barsalou A, Gao W, Anghel SI, Carrière J, Mader S. Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells. The Journal of Biological Chemistry. 273: 17138-46. PMID 9642281 DOI: 10.1074/Jbc.273.27.17138 |
0.653 |
|
| 1995 |
Haghighat A, Mader S, Pause A, Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. The Embo Journal. 14: 5701-9. PMID 8521827 DOI: 10.1002/J.1460-2075.1995.Tb00257.X |
0.319 |
|
| 1995 |
Mader S, Lee H, Pause A, Sonenberg N. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Molecular and Cellular Biology. 15: 4990-7. PMID 7651417 DOI: 10.1128/Mcb.15.9.4990 |
0.329 |
|
| 1994 |
Mader S, Thiele K, Breuer B, Alonso A. The promoter of the H1° histone gene contains a DNA element bound by retinoic acid receptors Journal of Molecular Biology. 242: 37-44. PMID 8078070 DOI: 10.1006/jmbi.1994.1555 |
0.355 |
|
| 1994 |
White JH, McCuaig KA, Mader S. A Simple and Sensitive High–Throughput Assay for Steroid Agonists and Antagonists Nature Biotechnology. 12: 1003-1007. PMID 7765403 DOI: 10.1038/Nbt1094-1003 |
0.471 |
|
| 1993 |
Mader S, Chambon P, White JH. Defining a minimal estrogen receptor DNA binding domain. Nucleic Acids Research. 21: 1125-32. PMID 8385312 DOI: 10.1093/Nar/21.5.1125 |
0.551 |
|
| 1993 |
Mader S, Chen J, Chen Z, White J, Chambon P, Gronemeyer H. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. The Embo Journal. 12: 5029-5041. DOI: 10.1002/J.1460-2075.1993.Tb06196.X |
0.522 |
|
| 1992 |
Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, Chambon P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently Cell. 68: 377-395. PMID 1310259 DOI: 10.1016/0092-8674(92)90478-U |
0.572 |
|
| 1991 |
Truss M, Chalepakis G, Slater EP, Mader S, Beato M. Functional interaction of hybrid response elements with wild-type and mutant steroid hormone receptors. Molecular and Cellular Biology. 11: 3247-58. PMID 2038329 DOI: 10.1128/Mcb.11.6.3247 |
0.512 |
|
| 1991 |
Vasios G, Mader S, Gold JD, Leid M, Lutz Y, Gaub MP, Chambon P, Gudas L. The late retinoic acid induction of laminin B1 gene transcription involves RAR binding to the responsive element. The Embo Journal. 10: 1149-1158. DOI: 10.1002/J.1460-2075.1991.Tb08055.X |
0.464 |
|
| 1990 |
Guerrier D, Boussin L, Mader S, Josso N, Kahn A, Picard J-. Expression of the gene for anti-Müllerian hormone. Reproduction. 88: 695-706. PMID 2325025 DOI: 10.1530/Jrf.0.0880695 |
0.436 |
|
| 1990 |
Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. The Embo Journal. 9: 4443-4454. DOI: 10.1002/J.1460-2075.1990.Tb07895.X |
0.518 |
|
| 1989 |
Mader S, Kumar V, Verneuil Hd, Chambon P. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature. 338: 271-274. PMID 2922054 DOI: 10.1038/338271A0 |
0.586 |
|
| 1988 |
Tora L, Gaub MP, Mader S, Dierich A, Bellard M, Chambon P. Cell-specific activity of a GGTCA half-palindromic oestrogen-responsive element in the chicken ovalbumin gene promoter. The Embo Journal. 7: 3771-3778. DOI: 10.1002/J.1460-2075.1988.Tb03261.X |
0.584 |
|
| Show low-probability matches. |